Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Saven

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Expert Review of Hematology|November 25, 2010
Hairy cell leukemia: current therapies and future directionsGregory S Vosganian, Darren S Sigal, Alan Saven
American Journal of Clinical Oncology|October 29, 2014
Retrospective analysis of relative dose intensity in patients with non-Hodgkin lymphoma receiving CHOP-based chemotherapy and pegfilgrastimLodovico Balducci, May Mo, Esteban Abella, et al.
Journal of Investigative Medicine High Impact Case Reports|May 28, 2016
Spontaneous Iliopsoas Muscle Hemorrhage Secondary to Ibrutinib (Imbruvica; Pharmacyclics): Brief ReportAnna Sarcon, Gregory P Botta, Nikunj Patel, et al.
Blood|January 9, 2010
Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribineDarren S Sigal, Robert Sharpe, Carol Burian, et al.
Blood|November 7, 2013
Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution seriesJoshua D Rosenberg, Carol Burian, Jill Waalen, et al.
Journal of Gastrointestinal Oncology|March 2, 2013
Masquerade without a mass: an unusual cause of severe acute pancreatitisChristina A To, Michael M Quigley, Alan Saven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Extended follow-up of patients with hairy cell leukemia after treatment with cladribineGrant R Goodman, Carol Burian, James A Koziol, et al.
Thrombosis and Haemostasis|August 23, 2005
Reactive thrombocytosis associated with a pheochromocytomaLyudmila Bazhenova, Emma Z Du, Sunil Bhoyrul, et al.
Leukemia & Lymphoma|July 16, 2011
Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22Weihsu C Chen, Darren S Sigal, Alan Saven, et al.
Blood|July 17, 2010
Beyond hairy cell: the activity of cladribine in other hematologic malignanciesDarren S Sigal, Heather J Miller, Ethan D Schram, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Expert Review of Hematology|November 25, 2010
Hairy cell leukemia: current therapies and future directionsGregory S Vosganian, Darren S Sigal, Alan Saven
American Journal of Clinical Oncology|October 29, 2014
Retrospective analysis of relative dose intensity in patients with non-Hodgkin lymphoma receiving CHOP-based chemotherapy and pegfilgrastimLodovico Balducci, May Mo, Esteban Abella, et al.
Journal of Investigative Medicine High Impact Case Reports|May 28, 2016
Spontaneous Iliopsoas Muscle Hemorrhage Secondary to Ibrutinib (Imbruvica; Pharmacyclics): Brief ReportAnna Sarcon, Gregory P Botta, Nikunj Patel, et al.
Blood|January 9, 2010
Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribineDarren S Sigal, Robert Sharpe, Carol Burian, et al.
Blood|November 7, 2013
Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution seriesJoshua D Rosenberg, Carol Burian, Jill Waalen, et al.
Journal of Gastrointestinal Oncology|March 2, 2013
Masquerade without a mass: an unusual cause of severe acute pancreatitisChristina A To, Michael M Quigley, Alan Saven, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Extended follow-up of patients with hairy cell leukemia after treatment with cladribineGrant R Goodman, Carol Burian, James A Koziol, et al.
Thrombosis and Haemostasis|August 23, 2005
Reactive thrombocytosis associated with a pheochromocytomaLyudmila Bazhenova, Emma Z Du, Sunil Bhoyrul, et al.
Leukemia & Lymphoma|July 16, 2011
Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22Weihsu C Chen, Darren S Sigal, Alan Saven, et al.
Blood|July 17, 2010
Beyond hairy cell: the activity of cladribine in other hematologic malignanciesDarren S Sigal, Heather J Miller, Ethan D Schram, et al.
Pageof 7